These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7152230)

  • 1. Effect of baclofen and haloperidol on gamma-aminobutyric acid and dopamine systems in an animal model of tardive dyskinesia.
    Rastogi SK; Rastogi RB; Lapierre YD; Singhal RL
    Gen Pharmacol; 1982; 13(6):499-504. PubMed ID: 7152230
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats.
    Kääriäinen I
    Acta Pharmacol Toxicol (Copenh); 1976 Sep; 39(3):393-400. PubMed ID: 989685
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats.
    Kaneda H; Shirakawa O; Dale J; Goodman L; Bachus SE; Tamminga CA
    Eur J Pharmacol; 1992 Feb; 212(1):43-9. PubMed ID: 1555638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal membrane 3H-dopamine binding in an animal model of tardive dyskinesia.
    Klawans HL; Hitri A
    Psychopharmacol Bull; 1978 Oct; 14(4):72-6. PubMed ID: 704768
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia.
    Ebadi M; Hama Y
    Neurosci Biobehav Rev; 1988; 12(3-4):179-87. PubMed ID: 2906420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SL76002 - effect on gamma-aminobutyric acid and dopamine in animals treated chronically with haloperidol.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Neuropsychobiology; 1983; 9(4):211-4. PubMed ID: 6646392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine-induced changes in dopamine and gamma aminobutyric acid in haloperidol withdrawn rats.
    Rastogi RB; Rastogi SK; Lapierre YD; Singhal RL
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):443-7. PubMed ID: 6891811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML; Trabucchi M
    Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
    [No Abstract]   [Full Text] [Related]  

  • 10. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, gamma-aminobutyric acid, gamma-hydroxybutyric acid, apomorphine and amphetamine.
    Kelly PH; Moore KE
    Neuropharmacology; 1978 Mar; 17(3):169-74. PubMed ID: 643163
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats.
    Grimm JW; See RE
    Neuroscience; 2000; 100(3):507-14. PubMed ID: 11098113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nullification by diazepam of haloperidol-induced increases in the level of striatal dopamine but not in the activity of glutamic acid decarboxylase.
    Hama Y; Ebadi M
    Neuropharmacology; 1986 Nov; 25(11):1235-42. PubMed ID: 3796796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in mouse brain dopamine content by baclofen: effects of apomorphine and neuroleptics.
    Gianutsos G; Moore KE
    Psychopharmacology (Berl); 1977 May; 52(3):217-21. PubMed ID: 406622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
    Reches A; Jackson-Lewis V; Fahn S
    Psychopharmacology (Berl); 1984; 82(4):330-4. PubMed ID: 6427824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.
    Gunne LM; Häggström JE; Sjöquist B
    Nature; 1984 May 24-30; 309(5966):347-9. PubMed ID: 6727989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral dyskinesia in rats after a single administration of haloperidol combined with GABA-linoleamide. A model of dyskinesia in man].
    Vamvakides A
    Agressologie; 1989 Feb; 30(2):89-91. PubMed ID: 2735495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists.
    Kalivas PW; Duffy P; Eberhardt H
    J Pharmacol Exp Ther; 1990 May; 253(2):858-66. PubMed ID: 2160011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.